Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Defining the Extracellular Matrix of Rhabdomyosarcoma.
Journal: Frontiers in oncology
Published: September 02, 2020
Volasertib preclinical activity in high-risk hepatoblastoma.
Journal: Oncotarget
Published: April 16, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Journal: Skeletal muscle
Published: January 10, 2019
The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.
Journal: Science signaling
Published: November 22, 2018
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Journal: Skeletal muscle
Published: November 19, 2018
NFκB signaling in alveolar rhabdomyosarcoma.
Journal: Disease models & mechanisms
Published: June 13, 2017
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.
Journal: PloS one
Published: March 12, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma.
Journal: Oncotarget
Published: December 07, 2016
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.
Journal: Scientific reports
Published: November 19, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026